Top compounds associated with response to ANKRD34A


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA ouabain CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.37 0.0002
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.12 0.0003
Download CSV